Childhood chronic pain

Roswell Infusions to Offer Promising New Treatment Against Mental Illness and Chronic Pain.

Retrieved on: 
Tuesday, August 16, 2022

ROSWELL, N.M., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Roswell Infusions announced today that it is accepting new patients for treatment of symptoms related to depression, PTSD, anxiety, and chronic pain.

Key Points: 
  • ROSWELL, N.M., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Roswell Infusions announced today that it is accepting new patients for treatment of symptoms related to depression, PTSD, anxiety, and chronic pain.
  • Ketamine Infusion Therapy (KIT) offers a new and effective treatment option for individuals who have not received relief from traditional medications to treat their mental health disorders and chronic pains.
  • Ketamine infusion therapy not only offers effective symptom management but enables the brain to create new pathways and truly heal from mental illness," says Laura King, LCSW, a Mental Health Consultant for Roswell Infusions.
  • Roswell Infusions' goal is to improve mental health in our communities.

Global Home Health Hubs Market to Reach $2.4 Billion by 2026

Retrieved on: 
Friday, March 11, 2022

SAN FRANCISCO, March 11, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Home Health Hubs - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, March 11, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Home Health Hubs - Global Market Trajectory & Analytics" .
  • Amid the COVID-19 crisis, the global market for Home Health Hubs estimated at US$751.1 Million in the year 2022, is projected to reach a revised size of US$2.4 Billion by 2026, growing at a CAGR of 35.8% over the analysis period.
  • This segment currently accounts for a 22.5% share of the global Home Health Hubs market.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Canada’s surgery backlog could lead to wave of new chronic pain and opioid dependencies

Retrieved on: 
Wednesday, July 21, 2021

TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- As Canada’s vaccination rates climb and hospitals begin to tackle the mountain of postponed surgeries due to the pandemic, we are facing an echo epidemic of new chronic pain sufferers. Studies show that roughly 30 per cent of those undergoing surgery will go on to develop chronic pain, and about 25 per cent of all chronic pain conditions originate from surgical procedures.1,2 This has a detrimental effect on families, communities and the healthcare system. However, with recent innovations in genetic testing this does not have to be the fate for the thousands of Canadians who are about to have surgery.

Key Points: 
  • Studies show that roughly 30 per cent of those undergoing surgery will go on to develop chronic pain, and about 25 per cent of all chronic pain conditions originate from surgical procedures.1,2 This has a detrimental effect on families, communities and the healthcare system.
  • However, with recent innovations in genetic testing this does not have to be the fate for the thousands of Canadians who are about to have surgery.
  • The risk of chronic pain following surgery is high.
  • The risk may be further compounded by the current echo pandemic of mental health issues, as depression and anxiety significantly increase the risk of developing chronic pain after surgery.

Study Involving Seven Major Children's Hospitals Shows COVID-19 is Typically Mild in Children

Retrieved on: 
Monday, November 23, 2020

More severe disease was seen in 7% of children with positive tests, with similar risk factors.

Key Points: 
  • More severe disease was seen in 7% of children with positive tests, with similar risk factors.
  • We are also learning that children with some, but not all, chronic conditions are more likely to have positive tests.
  • For example, we see this affect among children with diabetes, but not among children with asthma.
  • In addition, its unique family-centered care and public service programs have brought the 564-bed hospital recognition as a leading advocate for children and adolescents.

Help May Be On Its Way: 10% of World’s Population Suffers From Pain or Depression; US Nuclear and Grapheton Develop Neural Technology

Retrieved on: 
Tuesday, July 14, 2020

In fact, the total US economic burden of major depressive disorder is now estimated to be $210 billion per year*.

Key Points: 
  • In fact, the total US economic burden of major depressive disorder is now estimated to be $210 billion per year*.
  • Chronic pain and depression are extremely complex disorders that are incredibly hard to treat.
  • In addition to the physical pain, chronic pain activates areas of the brain that deal with depression and anxiety.
  • Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the companys website at www.usnuclearcorp.com

First Scientific Study Using Virtual Reality to Treat Chronic Pain at Home Finds AppliedVR Platform Feasible, Scalable and Effective

Retrieved on: 
Thursday, July 9, 2020

The study, which was published in JMIR-FR , found that a self-administered, skills-based VR treatment program was not only a feasible and scalable way to treat chronic pain, it also was effective at improving on multiple chronic pain outcomes.

Key Points: 
  • The study, which was published in JMIR-FR , found that a self-administered, skills-based VR treatment program was not only a feasible and scalable way to treat chronic pain, it also was effective at improving on multiple chronic pain outcomes.
  • Todays study sought to demonstrate the feasibility and efficacy of people using the AppliedVR program at home on themselves to manage their chronic pain.
  • People with chronic pain often have limited access to comprehensive pain care that includes skills-based behavioral medicine.
  • We tested whether VR that was self-administered at home would be an effective therapy for chronic pain, said Dr. Beth Darnall, AppliedVRs chief science advisor, who co-authored the study.

Flowly Offers Relief to 100 Million Americans Living with Chronic Pain and Anxiety

Retrieved on: 
Tuesday, June 9, 2020

Flowly today officially launched its interactive mobile app to address chronic pain and anxiety.

Key Points: 
  • Flowly today officially launched its interactive mobile app to address chronic pain and anxiety.
  • 100 million Americans of all ages suffer from chronic pain and anxiety, said Celine Tien, co-founder & CEO, Flowly.
  • Flowly is the first interactive platform to make pain management accessible, and address all parts of pain: physical, psychological, and even social.
  • Flowly Community Flowly offers a community component where users can share experiences, support one another, and share resources.

BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain

Retrieved on: 
Wednesday, October 2, 2019

The study demonstrated that users who experience pain relief after using ActiPatch for 7 days, continued to experience this relief over at least 6 months when ActiPatch use is continued.

Key Points: 
  • The study demonstrated that users who experience pain relief after using ActiPatch for 7 days, continued to experience this relief over at least 6 months when ActiPatch use is continued.
  • 240 Subjects were recruited into 6-month study of 7-day trial users of the ActiPatch medical device to treat chronic pain.
  • 7 days after initial treatment, average pain was reduced by 65%, from 8.2 to 2.9 on a 0-10 visual analog scale (VAS).
  • Sustained pain relief translated into improved quality of life and reduced medication use for the majority of the subjects.

Dallas Gets Infusion Center to Treat Depression, PTSD, Chronic Pain & Addiction

Retrieved on: 
Tuesday, July 23, 2019

To date, Kalypso has successfully treated patients from more than 32 different disease states including chronic pain, migraine headaches, fibromyalgia, depression and PTSD.

Key Points: 
  • To date, Kalypso has successfully treated patients from more than 32 different disease states including chronic pain, migraine headaches, fibromyalgia, depression and PTSD.
  • "At Principal Spine and Pain Consultants, we see patients on a daily basis in vast amounts of pain, either due to injuries or long-term diagnoses," explains Paul Kurian, M.D., board-certified pain management physician.
  • Principal Spine and Pain Consultants provides advanced pain management care for people who are faced with acute or chronic pain.
  • Our doctors are board-certified in pain management and have the experience and expertise to find the source of the pain in order to minimize or remove the pain.

HealthyWomen Hosts Science, Innovation and Technology Summit to Address Critical Challenges Associated with Chronic Pain in Women

Retrieved on: 
Wednesday, July 17, 2019

To advance current dialogue about the impact of chronic pain on women's health, HealthyWomen , the nation's leading independent, nonprofit health information source for women, is hosting its first science, innovation and technology summit specifically to address this issue.

Key Points: 
  • To advance current dialogue about the impact of chronic pain on women's health, HealthyWomen , the nation's leading independent, nonprofit health information source for women, is hosting its first science, innovation and technology summit specifically to address this issue.
  • During this two-day summit in Maryland, taking place July 1718, clinicians, researchers and advocates will convene to address knowledge gaps and challenges for treating and managing chronic pain in women.
  • "Women need to be taken seriously, and we need to eliminate the stigma associated with chronic pain.
  • Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults United States, 2016.